1. Respiratory Pharmacology Group, Division of Airway Disease, National Heart and Lung Institute, Imperial College London, United Kingdom
2. Innovative Medicines and Early Development, IMED RIA, AstraZeneca, Mölndal, Sweden
3. Division of Infection, Immunity, and Respiratory Medicine, University of Manchester, University Hospital of South Manchester, Manchester Academic Health Sciences Centre, Manchester, United Kingdom
4. Ario Pharma Ltd., Cambridgeshire, United Kingdom; and
5. Centre for Experimental Medicine, Queen’s University Belfast, Belfast, United Kingdom